Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Fast Start To Oral Phenylephrine Efficacy Complaints As US FDA Considers 'Any Action'
Class Action Complaints Don’t Wait For Potential Action On Oral Phenylephrine By US FDA
Sep 14 2023
•
By
Malcolm Spicer
• Source: Shutterstock
More from Regulation
More from Policy & Regulation